Alternate Dosing Schedules Study for HPV Vaccine (ADS)
Public ClinicalTrials.gov record NCT02280642. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Alternate Dosing Schedules Study for HPV Vaccine
Study identification
- NCT ID
- NCT02280642
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Duke University
- Other
- Enrollment
- 331 participants
Conditions and interventions
Conditions
Interventions
- Both 2nd and 3rd doses on time Biological
- 2nd dose late and 3rd dose on time Biological
- 2nd dose on time and 3rd dose late Biological
- Both doses late Biological
Biological
Eligibility (public fields only)
- Age range
- 9 Years to 18 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2009
- Primary completion
- Aug 31, 2012
- Completion
- Aug 31, 2012
- Last update posted
- Oct 30, 2014
2009 – 2012
United States locations
- U.S. sites
- 3
- U.S. states
- 1
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Chapel Hill Pediatrics | Chapel Hill | North Carolina | 27514 | — |
| Duke Children's Primary Care | Durham | North Carolina | 27704 | — |
| Durham Pediatrics | Durham | North Carolina | 27704 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02280642, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 30, 2014 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02280642 live on ClinicalTrials.gov.